Some specific alterations in TP53, CCNE1, GNAS, and PIK3CA are associated with chemotherapy resistance in hepatic cholangiocarcinoma, pancreatic cancer, and esophageal cancer [33]. Here, GNAS is linked to pancreatic neoplasm.